Balance Sheet Medicover AB

Equities

MCOV B

SE0009778848

Healthcare Facilities & Services

Real-time Estimate Cboe Europe Other stock markets 02:40:24 10/03/2026 pm IST			5-day change	1st Jan Change
210.25 ^SEK	+1.08%		+0.48%	-4.76%

09/03	Lancelot Sverige dipped 1.4 percent in February – lagged behind strong large-cap market	FW
13/02	PriorNilsson Evolve Down 4.85 Percent in January - Adds Medicover to Portfolio	FW

966cab5b4798a695443cf27b.VxKSmImlXr5DjT_cHJ22Qry9h3Q76faTW0fkCEbtWaE.FX_R0tbQJ4YE9VbtadfyMNrb600NiIb1LDG2cXDUL-JnYMPpvJQR_27reg

Published financial data: MEDICOVER AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	100Cr	137.74Cr	151.02Cr	174.64Cr	209.18Cr
Total Revenues	100Cr	137.74Cr	151.02Cr	174.64Cr	209.18Cr
Cost of Goods Sold, Total	73Cr	98Cr	116.98Cr	138.7Cr	164.35Cr
Gross Profit	26Cr	40Cr	34Cr	36Cr	45Cr
Selling General & Admin Expenses, Total	20Cr	23Cr	27Cr	30Cr	38Cr
Other Operating Expenses, Total	20Cr	23Cr	27Cr	30Cr	38Cr
Operating Income	6.8Cr	16Cr	6.9Cr	6.19Cr	7.32Cr
Interest Expense, Total	-1.81Cr	-2.01Cr	-3.45Cr	-5.14Cr	-5.88Cr
Interest And Investment Income	9L	10L	27L	44L	48L
Net Interest Expenses	-1.72Cr	-1.91Cr	-3.18Cr	-4.7Cr	-5.4Cr
Income (Loss) On Equity Invest.	1L	10L	2L	1L	-
Currency Exchange Gains (Loss)	-84L	18L	-33L	11L	34L
Other Non Operating Income (Expenses)	2L	3L	-	2L	4L
EBT, Excl. Unusual Items	4.27Cr	15Cr	3.41Cr	1.63Cr	2.3Cr
Merger & Related Restructuring Charges	-15L	-32L	-72L	-7L	-29L
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	13L	4L	-32L	-	-
Gain (Loss) On Sale Of Assets	-	-	-	78L	-
Asset Writedown	-52L	-	-63L	2L	-
Other Unusual Items	-	-	24L	-	-
EBT, Incl. Unusual Items	3.73Cr	14Cr	1.98Cr	2.36Cr	2.01Cr
Income Tax Expense	1Cr	3.72Cr	58L	52L	55L
Earnings From Continuing Operations	2.73Cr	11Cr	1.4Cr	1.84Cr	1.46Cr
Net Income to Company	2.73Cr	11Cr	1.4Cr	1.84Cr	1.46Cr
Minority Interest	-15L	-48L	-19L	-8L	21L
Net Income - (IS)	2.58Cr	10Cr	1.21Cr	1.76Cr	1.67Cr
Net Income to Common Incl Extra Items	2.58Cr	10Cr	1.21Cr	1.76Cr	1.67Cr
Net Income to Common Excl. Extra Items	2.58Cr	10Cr	1.21Cr	1.76Cr	1.67Cr
Per Share Items
Net EPS - Basic	0.18	0.69	0.08	0.12	0.11
Basic EPS - Continuing Operations	0.18	0.69	0.08	0.12	0.11
Basic Weighted Average Shares Outstanding	14Cr	15Cr	15Cr	15Cr	15Cr
Net EPS - Diluted	0.18	0.69	0.08	0.12	0.11
Diluted EPS - Continuing Operations	0.18	0.69	0.08	0.12	0.11
Diluted Weighted Average Shares Outstanding	14Cr	15Cr	15Cr	15Cr	15Cr
Normalized Basic EPS	0.18	0.59	0.13	0.06	0.11
Normalized Diluted EPS	0.18	0.59	0.13	0.06	0.11
Dividend Per Share	0.07	0.12	0.12	0.12	0.15
Payout Ratio	-	10.22	147.11	101.7	107.78
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	11Cr	22Cr	15Cr	16Cr	17Cr
EBITA	7.74Cr	17Cr	8.73Cr	8.24Cr	9.01Cr
EBIT	6.8Cr	16Cr	6.9Cr	6.19Cr	7.32Cr
EBITDAR	12Cr	23Cr	17Cr	18Cr	19Cr
Effective Tax Rate - (Ratio)	26.81	25.87	29.29	22.03	27.36
Total Current Taxes	1.36Cr	3.47Cr	1.09Cr	1.79Cr	2.65Cr
Total Deferred Taxes	-36L	25L	-51L	-1.27Cr	-2.1Cr
Normalized Net Income	2.52Cr	8.68Cr	1.94Cr	93.88L	1.65Cr
Interest on Long-Term Debt	1.02Cr	1.4Cr	2.21Cr	2.46Cr	2.78Cr
Supplemental Operating Expense Items
Selling and Marketing Expenses	4.33Cr	5.81Cr	6.65Cr	7.79Cr	9.78Cr
General and Administrative Expenses	15Cr	17Cr	20Cr	22Cr	28Cr
Research And Development Expense From Footnotes	23L	27L	43L	56L	70L
Net Rental Expense, Total	99L	1.42Cr	1.49Cr	1.96Cr	2.17Cr
Imputed Operating Lease Interest Expense	35.01L	40.36L	48.26L	82.93L	91.03L
Imputed Operating Lease Depreciation	63.99L	1.02Cr	1.01Cr	1.13Cr	1.26Cr
Stock-Based Comp., G&A Exp. (Total)	51L	69L	96L	94L	1.22Cr
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	51L	69L	96L	94L	1.22Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	4.67Cr	8.19Cr	4.04Cr	5.08Cr	6.98Cr
Short Term Investments	4.01Cr	20Cr	87L	1.12Cr	-
Trading Asset Securities, Total	-	-	10L	-	1.3Cr
Total Cash And Short Term Investments	8.68Cr	28Cr	5.01Cr	6.2Cr	8.28Cr
Accounts Receivable, Total	12Cr	15Cr	16Cr	18Cr	21Cr
Other Receivables	2.11Cr	4.18Cr	4.95Cr	6.93Cr	6.66Cr
Notes Receivable	-	-	-	-	-
Total Receivables	14Cr	19Cr	21Cr	25Cr	28Cr
Inventory	5.3Cr	7.2Cr	5.82Cr	5.94Cr	6.91Cr
Prepaid Expenses	1.1Cr	88L	1.32Cr	1.14Cr	1.58Cr
Other Current Assets, Total	-	-	-	24L	-
Total Current Assets	29Cr	55Cr	34Cr	38Cr	45Cr
Gross Property Plant And Equipment	70Cr	98Cr	124.05Cr	139.79Cr	161.92Cr
Accumulated Depreciation	-26Cr	-33Cr	-40Cr	-52Cr	-64Cr
Net Property Plant And Equipment	44Cr	65Cr	84Cr	88Cr	98Cr
Long-term Investments	1.75Cr	1.43Cr	52L	57L	52L
Goodwill	29Cr	37Cr	50Cr	52Cr	52Cr
Other Intangibles, Total	6.46Cr	7.51Cr	10Cr	9.3Cr	12Cr
Loans Receivable Long-Term	-	36L	23L	6L	5L
Deferred Tax Assets Long-Term	1.21Cr	1.19Cr	1.57Cr	2.73Cr	3.97Cr
Deferred Charges Long-Term	-	-	2.32Cr	2.92Cr	1.62Cr
Other Long-Term Assets, Total	-	94L	1.08Cr	1.15Cr	1.3Cr
Total Assets	111.09Cr	168.43Cr	183.17Cr	194.13Cr	213.82Cr
Liabilities
Accounts Payable, Total	5.36Cr	6.06Cr	6.1Cr	6.8Cr	8.95Cr
Accrued Expenses, Total	7.5Cr	8.91Cr	8.81Cr	9.95Cr	12Cr
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	1.51Cr	4.29Cr	4.23Cr	16Cr	18Cr
Current Portion of Leases	3.44Cr	4.61Cr	5.96Cr	7.06Cr	7.96Cr
Current Income Taxes Payable	78L	2.88Cr	2.55Cr	1.33Cr	1.57Cr
Unearned Revenue Current, Total	1.48Cr	2.02Cr	2.31Cr	98L	1.4Cr
Other Current Liabilities	2.76Cr	3.73Cr	5.4Cr	8.09Cr	6.89Cr
Total Current Liabilities	23Cr	32Cr	35Cr	50Cr	57Cr
Long-Term Debt	15Cr	38Cr	47Cr	41Cr	54Cr
Long-Term Leases	17Cr	30Cr	36Cr	37Cr	44Cr
Deferred Tax Liability Non Current	3Cr	3.53Cr	4.2Cr	4.12Cr	3.49Cr
Other Non Current Liabilities	5.12Cr	8.68Cr	8.72Cr	9.66Cr	6.71Cr
Total Liabilities	63Cr	112.22Cr	132.09Cr	141.3Cr	164.89Cr
Common Stock, Total	3.01Cr	3.04Cr	3.04Cr	3.07Cr	3.07Cr
Additional Paid In Capital	46Cr	46Cr	46Cr	46Cr	42Cr
Retained Earnings	5.09Cr	14Cr	13Cr	13Cr	7.35Cr
Treasury Stock	-4L	-7L	-6L	-8L	-7L
Comprehensive Income and Other	-9.13Cr	-11Cr	-14Cr	-12Cr	-5.67Cr
Total Common Equity	45Cr	52Cr	47Cr	50Cr	46Cr
Minority Interest	3.55Cr	4.45Cr	3.61Cr	3.18Cr	2.45Cr
Total Equity	48Cr	56Cr	51Cr	53Cr	49Cr
Total Liabilities And Equity	111.09Cr	168.43Cr	183.17Cr	194.13Cr	213.82Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	15Cr	15Cr	15Cr	15Cr	15Cr
ECS Total Common Shares Outstanding	15Cr	-	-	15Cr	15Cr
Book Value / Share	3.02	3.49	3.19	3.32	3.1
Tangible Book Value	9.42Cr	7.08Cr	-12Cr	-11Cr	-18Cr
Tangible Book Value Per Share	0.64	0.48	-0.83	-0.76	-1.17
Total Debt	37Cr	76Cr	94Cr	100.37Cr	123.89Cr
Net Debt	28Cr	49Cr	89Cr	94Cr	115.61Cr
Debt Equivalent Oper. Leases	7.92Cr	11Cr	12Cr	16Cr	17Cr
Minority Interest, Total (Incl. Fin. Div)	3.55Cr	4.45Cr	3.61Cr	3.18Cr	2.45Cr
Equity Method Investments, Total	76L	85L	8L	8L	7L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	4.15Cr	6Cr	4.41Cr	4.23Cr	4.88Cr
Inventories - Finished Goods, Total	1.15Cr	1.2Cr	98L	1.25Cr	64L
Inventories - Others	-	-	43L	46L	1.39Cr
Land - (BS)	12Cr	13Cr	16Cr	17Cr	18Cr
Machinery, Total	20Cr	27Cr	32Cr	38Cr	44Cr
Full Time Employees	32.39T	38.56T	44.71T	45.32T	47.26T
Accumulated Allowance for Doubtful Accounts (Supple)	1.34Cr	1.21Cr	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	2.58Cr	10Cr	1.21Cr	1.76Cr	1.67Cr
Depreciation & Amortization - CF	7.52Cr	9.32Cr	13Cr	15Cr	17Cr
Amortization of Goodwill and Intangible Assets - (CF)	94L	1.1Cr	1.83Cr	2.05Cr	1.69Cr
Depreciation & Amortization, Total	8.46Cr	10Cr	15Cr	17Cr	18Cr
Amortization of Deferred Charges, Total - (CF)	64L	68L	95L	1.24Cr	1.51Cr
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-13L	-4L	13L	-	-
Asset Writedown & Restructuring Costs	52L	-	27L	-2L	1.64Cr
Stock-Based Compensation (CF)	47L	64L	96L	94L	1.22Cr
Other Operating Activities, Total	3.13Cr	3.88Cr	2.52Cr	1Cr	3.64Cr
Change In Accounts Receivable	-2.84Cr	-4.95Cr	-2.67Cr	-2.91Cr	-5.33Cr
Change In Inventories	-2.2Cr	-1.71Cr	1.27Cr	-51L	-82L
Change In Accounts Payable	4.97Cr	2.57Cr	-2.59Cr	1.98Cr	4.35Cr
Cash from Operations	16Cr	22Cr	17Cr	20Cr	26Cr
Capital Expenditure	-7.25Cr	-10Cr	-14Cr	-11Cr	-12Cr
Sale of Property, Plant, and Equipment	9L	21L	30L	14L	22L
Cash Acquisitions	-1.22Cr	-8.75Cr	-23Cr	-1.96Cr	-1.81Cr
Divestitures	-	-	-	1.4Cr	1L
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-4.36Cr	-14Cr	18Cr	-16L	-23L
Net (Increase) Decrease in Loans Originated / Sold - Investing	-1L	-28L	-	-75L	1L
Other Investing Activities, Total	12L	10L	18L	40L	56L
Cash from Investing	-13Cr	-33Cr	-18Cr	-12Cr	-13Cr
Long-Term Debt Issued, Total	18Cr	29Cr	52Cr	46Cr	88Cr
Total Debt Issued	18Cr	29Cr	52Cr	46Cr	88Cr
Long-Term Debt Repaid, Total	-32Cr	-9.32Cr	-49Cr	-46Cr	-83Cr
Total Debt Repaid	-32Cr	-9.32Cr	-49Cr	-46Cr	-83Cr
Issuance of Common Stock	14Cr	3L	-	3L	-
Repurchase of Common Stock	-	-3L	-	-3L	-
Common Dividends Paid	-	-1.04Cr	-1.78Cr	-1.79Cr	-1.8Cr
Common & Preferred Stock Dividends Paid	-	-1.04Cr	-1.78Cr	-1.79Cr	-1.8Cr
Other Financing Activities, Total	-1.93Cr	-2.6Cr	-4.53Cr	-5.49Cr	-15Cr
Cash from Financing	-1.41Cr	16Cr	-2.43Cr	-7.37Cr	-11Cr
Foreign Exchange Rate Adjustments	-37L	-1.2Cr	-26L	-11L	-2L
Net Change in Cash	1.19Cr	3.52Cr	-4.15Cr	1.04Cr	1.9Cr
Supplemental Items
Cash Interest Paid	1.58Cr	1.97Cr	3.24Cr	4.65Cr	5.94Cr
Cash Income Tax Paid (Refund)	1.1Cr	1.83Cr	1.91Cr	2.88Cr	1.92Cr
Levered Free Cash Flow	7.46Cr	9.07Cr	5.41Cr	7.09Cr	8.9Cr
Unlevered Free Cash Flow	8.59Cr	10Cr	7.56Cr	10Cr	13Cr
Change In Net Working Capital	-1.98Cr	1.41Cr	-43L	1.72Cr	81L
Net Debt Issued / Repaid	-14Cr	20Cr	3.88Cr	-9L	5.56Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.98	7.27	2.45	2.05	2.24
Return on Total Capital	5.11	9.34	3.11	2.6	2.81
Return On Equity %	6.48	20.39	2.61	3.55	2.87
Return on Common Equity	6.74	21.09	2.44	3.63	3.47
Margin Analysis
Gross Profit Margin %	26.48	28.68	22.54	20.58	21.43
SG&A Margin	19.66	16.87	17.97	17.04	17.93
EBITDA Margin %	11.4	16.02	10.13	8.95	8.18
EBITA Margin %	7.76	12.6	5.78	4.72	4.31
EBIT Margin %	6.81	11.8	4.57	3.54	3.5
Income From Continuing Operations Margin %	2.74	7.74	0.93	1.05	0.7
Net Income Margin %	2.59	7.39	0.8	1.01	0.8
Net Avail. For Common Margin %	2.59	7.39	0.8	1.01	0.8
Normalized Net Income Margin	2.52	6.3	1.29	0.54	0.79
Levered Free Cash Flow Margin	7.48	6.58	3.58	4.06	4.25
Unlevered Free Cash Flow Margin	8.61	7.49	5.01	5.9	6.01
Asset Turnover
Asset Turnover	0.94	0.99	0.86	0.93	1.03
Fixed Assets Turnover	2.33	2.54	2.03	2.04	2.26
Receivables Turnover (Average Receivables)	8.9	10.26	9.58	10.24	10.75
Inventory Turnover (Average Inventory)	16.28	15.72	17.97	23.59	25.58
Short Term Liquidity
Current Ratio	1.27	1.7	0.95	0.76	0.79
Quick Ratio	0.99	1.45	0.75	0.62	0.64
Operating Cash Flow to Current Liabilities	0.68	0.67	0.48	0.41	0.46
Days Sales Outstanding (Average Receivables)	41.12	35.56	38.1	35.63	34.05
Days Outstanding Inventory (Average Inventory)	22.48	23.22	20.31	15.47	14.31
Average Days Payable Outstanding	24.03	20.81	19.2	16.96	17.43
Cash Conversion Cycle (Average Days)	39.57	37.97	39.22	34.15	30.92
Long Term Solvency
Total Debt/Equity	75.99	135.94	184.02	189.99	253.2
Total Debt / Total Capital	43.18	57.62	64.79	65.52	71.69
LT Debt/Equity	65.75	120.1	164.08	146.62	200.41
Long-Term Debt / Total Capital	37.36	50.9	57.77	50.56	56.74
Total Liabilities / Total Assets	56.48	66.63	72.11	72.79	77.12
EBIT / Interest Expense	3.76	8.09	2	1.2	1.24
EBITDA / Interest Expense	8.43	13.27	6.34	4.52	4.36
(EBITDA - Capex) / Interest Expense	4.43	8.19	2.26	2.37	2.28
Total Debt / EBITDA	2.41	2.86	4.3	4.32	4.83
Net Debt / EBITDA	1.84	1.82	4.07	4.06	4.51
Total Debt / (EBITDA - Capex)	4.59	4.64	12.04	8.25	9.25
Net Debt / (EBITDA - Capex)	3.5	2.95	11.39	7.74	8.63
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.17	38.04	9.64	15.64	19.78
Gross Profit, 1 Yr. Growth %	27.45	49.51	-13.82	5.67	24.74
EBITDA, 1 Yr. Growth %	33.88	92.83	-30.64	2.36	9.53
EBITA, 1 Yr. Growth %	37.23	124.29	-49.71	-5.29	9.34
EBIT, 1 Yr. Growth %	36.82	139.12	-57.56	-9.9	18.26
Earnings From Cont. Operations, 1 Yr. Growth %	10.53	290.48	-86.87	34.31	-20.65
Net Income, 1 Yr. Growth %	14.67	294.57	-88.11	49.15	-5.11
Normalized Net Income, 1 Yr. Growth %	-1.42	244.71	-77.64	-54.7	75.5
Diluted EPS Before Extra, 1 Yr. Growth %	8.33	276.93	-88.19	49.16	-5.48
Accounts Receivable, 1 Yr. Growth %	9.73	28.82	8.67	7.67	20.14
Inventory, 1 Yr. Growth %	42.86	35.85	-19.17	2.06	16.33
Net Property, Plant and Equip., 1 Yr. Growth %	4.68	47.55	29.98	4.18	11.43
Total Assets, 1 Yr. Growth %	8.58	51.62	8.75	5.95	10.14
Tangible Book Value, 1 Yr. Growth %	-274.77	-24.84	-254.42	-10.13	36.35
Common Equity, 1 Yr. Growth %	41.15	15.54	-8.29	5.1	-6.38
Cash From Operations, 1 Yr. Growth %	78.69	39.72	-21.46	20.45	27.76
Capital Expenditures, 1 Yr. Growth %	14.72	40.97	37.57	-21.41	10.68
Levered Free Cash Flow, 1 Yr. Growth %	63.57	21.55	-40.37	25.03	25.6
Unlevered Free Cash Flow, 1 Yr. Growth %	58.6	20.17	-26.74	31.63	22.1
Dividend Per Share, 1 Yr. Growth %	-	71.43	0	0	25
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.89	27.72	23.03	12.6	17.69
Gross Profit, 2 Yr. CAGR %	26.81	38.04	13.51	-4.61	14.81
EBITDA, 2 Yr. CAGR %	34.72	61.1	15.65	-15.83	5.88
EBITA, 2 Yr. CAGR %	38.93	75.44	6.2	-31.1	1.77
EBIT, 2 Yr. CAGR %	38.4	80.88	0.73	-38.3	3.22
Earnings From Cont. Operations, 2 Yr. CAGR %	6.21	107.74	-28.39	-58.45	3.23
Net Income, 2 Yr. CAGR %	7.56	112.71	-31.52	-58.42	18.96
Normalized Net Income, 2 Yr. CAGR %	14.84	84.34	-12.21	-67.12	-10.84
Diluted EPS Before Extra, 2 Yr. CAGR %	4.39	102.07	-33.29	-58.55	18.74
Accounts Receivable, 2 Yr. CAGR %	30.67	18.89	18.31	8.17	13.73
Inventory, 2 Yr. CAGR %	32.26	39.31	4.79	-9.17	8.96
Net Property, Plant and Equip., 2 Yr. CAGR %	24.8	24.28	38.49	16.37	7.74
Total Assets, 2 Yr. CAGR %	23.5	28.31	28.41	7.36	8.03
Tangible Book Value, 2 Yr. CAGR %	-8.37	14.61	14.73	18.89	18.15
Common Equity, 2 Yr. CAGR %	19.62	27.7	2.94	-2.06	-0.81
Cash From Operations, 2 Yr. CAGR %	44.8	57.55	4.75	-2.74	24.05
Capital Expenditures, 2 Yr. CAGR %	32.98	27.16	39.26	3.98	-6.73
Levered Free Cash Flow, 2 Yr. CAGR %	355.97	41	-14.86	-11.59	25.31
Unlevered Free Cash Flow, 2 Yr. CAGR %	199.33	38.05	-6.17	-0.12	26.78
Dividend Per Share, 2 Yr. CAGR %	-	-	30.93	0	11.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	19.81	27.05	21.38	20.51	14.94
Gross Profit, 3 Yr. CAGR %	22.99	33.96	17.98	10.8	4.31
EBITDA, 3 Yr. CAGR %	29.17	52.09	21.64	10.96	-8.1
EBITA, 3 Yr. CAGR %	33.54	62.98	15.68	2.11	-19.64
EBIT, 3 Yr. CAGR %	33.16	66.07	11.56	-3.08	-23.36
Earnings From Cont. Operations, 3 Yr. CAGR %	10.56	63.93	-17.24	-12.32	-48.45
Net Income, 3 Yr. CAGR %	11.32	65.89	-18.68	-11.97	-45.26
Normalized Net Income, 3 Yr. CAGR %	18.21	65.65	-8.75	-28.04	-42.54
Diluted EPS Before Extra, 3 Yr. CAGR %	5.07	60.15	-21.59	-13.49	-45.45
Accounts Receivable, 3 Yr. CAGR %	23.35	30.05	15.38	14.66	12.02
Inventory, 3 Yr. CAGR %	19.96	33.44	16.19	3.87	-1.36
Net Property, Plant and Equip., 3 Yr. CAGR %	43.32	31.97	26.15	25.95	14.7
Total Assets, 3 Yr. CAGR %	30.16	32.24	21.43	20.45	8.28
Tangible Book Value, 3 Yr. CAGR %	-11.76	-14.23	32.01	6.41	29.97
Common Equity, 3 Yr. CAGR %	14.26	18.24	14.36	3.49	-3.52
Cash From Operations, 3 Yr. CAGR %	45.83	42.81	24.92	9.74	6.52
Capital Expenditures, 3 Yr. CAGR %	35.1	35.59	30.54	15.08	6.17
Levered Free Cash Flow, 3 Yr. CAGR %	49.92	193.46	5.84	-1.69	-0.62
Unlevered Free Cash Flow, 3 Yr. CAGR %	50.5	120.81	11.77	6.23	6.8
Dividend Per Share, 3 Yr. CAGR %	-	-	-	19.68	7.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	19.14	22.6	21.09	21.06	19.89
Gross Profit, 5 Yr. CAGR %	21.28	26.91	19.11	16.95	16.68
EBITDA, 5 Yr. CAGR %	24.4	38.68	23.71	20.04	15.03
EBITA, 5 Yr. CAGR %	26.07	47.82	21.85	15.49	9.82
EBIT, 5 Yr. CAGR %	25.9	50.44	19.09	11.76	8.05
Earnings From Cont. Operations, 5 Yr. CAGR %	24.85	74.97	-7.07	-5.33	-9.98
Net Income, 5 Yr. CAGR %	28.03	88.3	-8.34	-4.62	-5.79
Normalized Net Income, 5 Yr. CAGR %	22.68	62.45	4.95	-13.24	-8.4
Diluted EPS Before Extra, 5 Yr. CAGR %	-14.05	72.43	-12.39	-6.74	-7.89
Accounts Receivable, 5 Yr. CAGR %	22.46	20.49	21.31	20.81	14.72
Inventory, 5 Yr. CAGR %	16.97	22.78	13.65	14.41	13.25
Net Property, Plant and Equip., 5 Yr. CAGR %	40.7	35.46	41.36	25.49	18.44
Total Assets, 5 Yr. CAGR %	28.85	32.05	29.46	21.66	15.88
Tangible Book Value, 5 Yr. CAGR %	20.88	4.25	-1.99	0.23	26.75
Common Equity, 5 Yr. CAGR %	38.1	41.05	9.59	9.66	7.93
Cash From Operations, 5 Yr. CAGR %	40.3	52.94	27.61	22.47	24.57
Capital Expenditures, 5 Yr. CAGR %	18.67	17.52	36.75	21.93	14.11
Levered Free Cash Flow, 5 Yr. CAGR %	60.17	26.68	19.55	81.6	14.31
Unlevered Free Cash Flow, 5 Yr. CAGR %	74.81	32.88	24.58	60.77	18.35